Asian biopharmaceutical firm SeriTech, which has a subsidiary in Barcelona and is a CataloniaBio & HealthTech member, has hired cardiovascular surgeon Manuel Galiñanes as its new Chief Medical Officer.

Galiñanes has a PhD in Physiology and Biochemistry from the University of London, a degree in Medicine from the University of Salamanca and in Cardiovascular Surgery from the Complutense University of Madrid. He practised for over 20 years in the United Kingdom, United States and Canada and has been head of Cardiac Surgery at Vall d’Hebron Hospital and co-founder of the European Society of Cardiology’s working group on Cell Therapy. 

SeriTech Co Ltd specialises in extracting natural silk proteins, which have been scientifically proven for biomedical, therapeutic and cosmetic uses. "I see a tremendous potential for silk proteins to improve patient lives suffering from heart diseases, due to the strong biocompatible and anti-oxidant properties of sericin and fibroin" he said.

You may also be interested in:

Biopharmaceutical firm SeriTech to establish new European subsidiary in Barcelona

Want to know more about SeriTech? We recommend this video of CataloniaBio & HealthTech interviewing them: